DE69133295D1 - 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE69133295D1
DE69133295D1 DE69133295T DE69133295T DE69133295D1 DE 69133295 D1 DE69133295 D1 DE 69133295D1 DE 69133295 T DE69133295 T DE 69133295T DE 69133295 T DE69133295 T DE 69133295T DE 69133295 D1 DE69133295 D1 DE 69133295D1
Authority
DE
Germany
Prior art keywords
alkyl
phenyl
nonanyl
diazabicyclo
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69133295T
Other languages
English (en)
Other versions
DE69133295T2 (de
Inventor
F D King
Anthony Gregory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE69133295D1 publication Critical patent/DE69133295D1/de
Publication of DE69133295T2 publication Critical patent/DE69133295T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69133295T 1990-09-26 1991-09-23 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen Expired - Lifetime DE69133295T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909020927A GB9020927D0 (en) 1990-09-26 1990-09-26 Pharmaceuticals
GB9020927 1990-09-26
PCT/GB1991/001629 WO1992005174A1 (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DE69133295D1 true DE69133295D1 (de) 2003-08-21
DE69133295T2 DE69133295T2 (de) 2004-03-18

Family

ID=10682769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133295T Expired - Lifetime DE69133295T2 (de) 1990-09-26 1991-09-23 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen

Country Status (19)

Country Link
EP (1) EP0550550B1 (de)
JP (1) JP2831464B2 (de)
KR (1) KR100200438B1 (de)
AT (1) ATE245157T1 (de)
AU (1) AU652187B2 (de)
CA (1) CA2092431C (de)
CY (1) CY2387B1 (de)
DE (1) DE69133295T2 (de)
DK (1) DK0550550T3 (de)
ES (1) ES2203609T3 (de)
GB (1) GB9020927D0 (de)
HK (1) HK1012356A1 (de)
IE (1) IE913352A1 (de)
MX (1) MX9101236A (de)
NZ (1) NZ239915A (de)
PT (1) PT99028B (de)
TW (1) TW240227B (de)
WO (1) WO1992005174A1 (de)
ZA (1) ZA917606B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121170D0 (en) * 1991-10-05 1991-11-20 Smithkline Beecham Plc Pharmaceuticals
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
KR100783863B1 (ko) 2002-04-29 2007-12-10 액테리온 파마슈티칼 리미티드 7-아릴-3,9-디아자바이사이클로(3.3.1)논-6-엔 유도체 및고혈압, 심혈관 질환 또는 신장 질환의 치료에서 레닌저해물질로써 이들의 용도
JP2007508262A (ja) * 2003-10-13 2007-04-05 アクテリオン　ファマシューティカルズ　リミテッド 新規ジアザビシクロノネン誘導体およびその使用
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
KR100875558B1 (ko) 2004-06-15 2008-12-23 화이자 인코포레이티드 벤즈이미다졸론 카복실산 유도체
EP1856110B1 (de) 2005-02-22 2011-06-22 Pfizer Inc. Oxyindol-derivate als 5ht4-rezeptor-agonisten
US8129538B1 (en) 2007-03-28 2012-03-06 Takeda Pharmaceutical Company Limited Renin inhibitors
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498466B1 (de) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Derivate von Indazole-3-carboxamide und -3-carboxylsäure
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
US4920227A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Benzobicyclic carboxamide 5-HT3 antagonists
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents

Also Published As

Publication number Publication date
TW240227B (de) 1995-02-11
HK1012356A1 (en) 1999-07-30
PT99028A (pt) 1993-10-29
EP0550550B1 (de) 2003-07-16
GB9020927D0 (en) 1990-11-07
MX9101236A (es) 1992-05-04
ZA917606B (en) 1992-09-30
DE69133295T2 (de) 2004-03-18
ES2203609T3 (es) 2004-04-16
ATE245157T1 (de) 2003-08-15
KR930702345A (ko) 1993-09-08
JPH06501256A (ja) 1994-02-10
DK0550550T3 (da) 2003-09-08
EP0550550A1 (de) 1993-07-14
CA2092431C (en) 2002-12-10
CA2092431A1 (en) 1992-03-27
PT99028B (pt) 1999-02-26
AU8624491A (en) 1992-04-15
NZ239915A (en) 1993-11-25
KR100200438B1 (ko) 1999-06-15
AU652187B2 (en) 1994-08-18
WO1992005174A1 (en) 1992-04-02
IE913352A1 (en) 1992-04-08
CY2387B1 (en) 2004-09-10
JP2831464B2 (ja) 1998-12-02

Similar Documents

Publication Publication Date Title
DE69133295D1 (de) 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen
EA199800404A1 (ru) Производные 1-(1,2-дизамещенный пиперидинил)-4-замещенного пиперазина
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
ATE208779T1 (de) Substituierte spiroheterocyclische 1h-3-aryl- pyrrolidin-2,4-dion-derivate, verfahren zu deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
DK633088A (da) Kollagenaseinhibitorer
ES2061663T3 (es) Derivados de carbamoilpirrolidina, su uso y preparacion.
SE8604950L (sv) Demensforbettrande och terapeutiska medel
DE3670081D1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
PT83725B (pt) Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem
SE8000920L (sv) 4-(naftylmetyl)piperidinderivat
DE69828284D1 (de) Naphthyridinderivate oder salze davon
MX9205207A (es) Derivados de dihidropiridina, procedimiento para su preparacion y composicion farmaceutica que los comprende
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
DK37580A (da) 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater samt deres fremstilling og anvendelse
SE8303913D0 (sv) Heterocykliska foreningar
ES8305359A1 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
ATE124685T1 (de) 4-phenylmethyl-1h-indol-derivate, verfahren und zwischenverbindungen zu deren herstellung, anwendung als arzneimittel und diese enthaltende zusammensetzungen.
ES531933A0 (es) Un procedimiento para preparar un derivado de imidazolinona
SE8207294D0 (sv) 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar
ES2055123T3 (es) Nuevos derivados de la fenotiazina, su preparacion y las composiciones que les contienen.
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
IE820160L (en) Heterocyclic benzamide derivatives
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition